← All organizations
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
GovernmentWebsite ↗
Also known as: National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)
Highest phase reached
Phase 4
First clinical trial
Mar 1, 1976Last known activity
Jul 1, 2026
Timeline
1950s
- Jan 1, 1950
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)— Founded
Drugs by trial phase (482 distinct, 736 trials)
Phase 4 (90 own, 0 via acquisition)
Phase 3 (94 own, 0 via acquisition)
Phase 2 (166 own, 0 via acquisition)
Phase 1 (59 own, 0 via acquisition)
Other trials (73 own, 0 via acquisition)
Indications
Studied for
- Abdominal Pain
- Acidosis
- Acquired Immunodeficiency Syndrome
- Acromegaly
- ACTH-Secreting Pituitary Adenoma
- Acute Kidney Injury
- Adenoma
- Adenoma, Islet Cell
- Albuminuria
- alpha 1-Antitrypsin Deficiency
- Alzheimer Disease
- Anemia
- Anemia, Hemolytic
- Anemia, Iron-Deficiency
- Anemia, Sickle Cell
- Anorexia
- Anorexia Nervosa
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
- Apnea
- Appendicitis
- Atherosclerosis
- Autoimmune Diseases
- Beriberi
- beta-Thalassemia
- Biliary Atresia
- Binge-Eating Disorder
- Body Weight
- Body Weight Changes
- Bone Diseases
- Bone Diseases, Endocrine
- Bone Diseases, Metabolic
- Brain Diseases
- Bulimia
- Cachexia
- Calcinosis
- Calculi
- Cardiac Complexes, Premature
- Cardiovascular Diseases
- Cerebral Palsy
- Chest Pain
- Cholangitis
- Cholangitis, Sclerosing
- Cholestasis
- Chronic Disease
- Chronic Kidney Disease-Mineral and Bone Disorder
- Chronic Pain
- Colitis
- Colitis, Ulcerative
- Colonic Diseases
- Colonic Diseases, Functional
- Communicable Diseases
- Congenital Hyperinsulinism
- Constipation
- Coronary Artery Disease
- Coronary Disease
- Critical Illness
- Crohn Disease
- Cushing Syndrome
- Cystic Fibrosis
- Cystinuria
- Cystitis
- Cystitis, Interstitial
- Deficiency Diseases
- Delayed Graft Function
- Depression
- Depressive Disorder
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Diabetic Foot
- Diabetic Ketoacidosis
- Diabetic Nephropathies
- Diarrhea
- Digestive System Diseases
- Disease Progression
- Disease Susceptibility
- Dysbiosis
- Dyslipidemias
- Dysmenorrhea
- Dyspepsia
- Emergencies
- Endocrine System Diseases
- Endometriosis
- Enterocolitis
- Enterocolitis, Necrotizing
- Enuresis
- Eosinophilic Esophagitis
- Esophageal and Gastric Varices
- Esophagitis
- Essential Hypertension
- Exocrine Pancreatic Insufficiency
- Eye Diseases
- Familial Primary Pulmonary Hypertension
- Fatigue
- Fatty Liver
- Fecal Incontinence
- Feeding and Eating Disorders
- Fibrosis
- Fistula
- Foot Ulcer
Recent trials (50)
- NCT07211802CollaboratorPhase 3Jul 1, 2026
- NCT07300982CollaboratorPhase 1/Phase 2Apr 30, 2026
- NCT07225465CollaboratorPhase 2Feb 28, 2026
- NCT07053319CollaboratorPhase 1Feb 1, 2026
- NCT07273838CollaboratorPhase 2Jan 31, 2026
- NCT07056699CollaboratorPhase 3Jan 30, 2026
- NCT07209202CollaboratorN/ADec 31, 2025
- NCT07084129CollaboratorPhase 1Dec 31, 2025
- NCT07084441CollaboratorPhase 4Dec 31, 2025
- NCT06983730CollaboratorEarly Phase 1Dec 31, 2025
- NCT06991738OfficialPhase 1/Phase 2Dec 2, 2025
- NCT06991738Lead sponsorPhase 1/Phase 2Dec 2, 2025
- NCT06907199CollaboratorPhase 1Dec 1, 2025
- NCT07216391Lead sponsorPhase 2Dec 1, 2025
- NCT07212868CollaboratorPhase 1Dec 1, 2025
Details
- Founded
- Bethesda, MA, US Jan 1, 1950
- Last known activity
- Jul 1, 2026